INO has been in the news 375% more than usual
Feb 27, 2026, 7:31 PM
-8.73%
What does INO do
Inovio Pharmaceuticals, based in San Diego, develops DNA medicines targeting infectious diseases, cancer, and HPV-related conditions, with key candidates including INO-3107 for recurrent respiratory papillomatosis. The company employs 122 people and utilizes CELLECTRA devices for DNA delivery.
INO has been in the news recently: Investors who incurred losses from Inovio Pharmaceuticals, Inc. between October 10, 2023, and December 26, 2025, can join a class action lawsuit for federal securities law violations, with a deadline of April 7, 2026. Multiple law firms are urging affected investors to take action before the deadline.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.